Journal Article

Novel potentials of the DPP-4 inhibitor sitagliptin against ischemia-reperfusion (I/R) injury in rat ex-vivo heart model

Varga C, Szab? R, Murlasits Z, Sz?cs G, Takacs I, T?r?k S, Al-Awar A, Alm?si N, Kupai K, P?sa A

2018

Overview

Dipeptidyl peptidase-4 (DPP-4) inhibitors are a class of oral anti-diabetic drugs, implicated in pleiotropic secondary cardioprotective effects. The aim of the study was to unveil the unknown and possible cardioprotective targets that can be exerted by sitagliptin (Sitg) against ischemia-reperfusion (I/R) injury. Male wistar rats received 2 weeks? Sitg oral treatment of different doses (25, 50, 100, and 150 mg/kg/day), or saline as a Control. Hearts were then isolated and subjected to two different I/R injury protocols: 10 min perfusion, 45 min regional ischemia, and 120 min reperfusion for infarct size (IS) measurement, or: 10 min perfusion, 45 min regional ischemia and 10 min reperfusion for biochemical analysis: nitric oxide synthases (NOSs) and DPP-4 activity, glucagon-like peptide-1 (GLP-1), Calcium, transient receptor potential vanilloid (TRPV)-1 and calcitonin gene-related peptide (CGRP) levels, transient receptor potential canonical (TRPC)-1 and e-NOS protein expression. NOS inhibitor (L-NAME) and TRPV-1 inhibitor (Capsazepine) were utilized to confirm the implication of both signaling mechanisms in DPP-4 inhibition-induced at the level of IS. Findings show that Sitg (50 mg) resulted in significant decrease in IS and DPP-4 activity, and significant increase in GLP-1, NOS activity, e-NOS expression, TRPV-1 level and TRPC-1 expression, compared to controls. Results of CGRP are in line with TRPV-1, as a downstream regulatory effect. NOS system and transient receptor potential (TRP) channels can contribute to DPP-4 inhibition-mediated cardioprotection against I/R injury using Sitagliptin.

• Publisher: MDPI AG,MDPI
• Subject: Animals / Biomarkers / Calcium - metabolism / Dipeptidyl Peptidase 4 - metabolism / Dipeptidyl-Peptidase IV Inhibitors - pharmacology / Disease Models, Animal / Glucagon-Like Peptide 1 - metabolism / Male / Myocardial Reperfusion Injury - drug therapy / Myocardial Reperfusion Injury - metabolism / Myocardial Reperfusion Injury - pathology / Myocardium - metabolism / Myocardium - pathology / Nitric Oxide Synthase Type III - genetics / Nitric Oxide Synthase Type III - metabolism / Protective Agents - pharmacology / Rats / Receptors, Calcitonin Gene-Related Peptide - metabolism / Sitagliptin Phosphate - pharmacology / TRPV Cation Channels - metabolism